Private Investors Inject $104M Into Encoded Therapeutics
Encoded Therapeutics Inc., a San Francisco-based biotech focused on developing treatments for severe genetic disorders including liver and cardiovascular disease, said Wednesday that it has collected $104 million from a group...To view the full article, register now.
Already a subscriber? Click here to view full article